Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.10
Delayed Data
As of May 27
 +0.05 / +0.55%
Today’s Change
5.57
Today|||52-Week Range
10.95
-15.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash18.5M33.5M73.7M81.7M
 
 
 
 
 
Short Term Investment Cash2.4M14.9M40.2M8.1M
 
 
 
 
 
Cash & Short Term Investments65.4M121.9M152.9M459.3M
 
 
 
 
 
 
ReceivablesReceivables1.1M1.8M1.3M2.3M
 
 
 
 
 
 
InventoriesInventories0.00----0.00--
 
Current AssetsPrepaid Expenses1.2M783.0K285.0K633.0K
 
 
 
 
 
Other Current Assets219.0K371.0K387.0K269.0K
 
 
 
 
 
Current Assets67.9M124.8M154.9M462.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross6.6M6.7M7.5M8.0M
 
 
 
 
 
Depreciation-5.3M-5.4M-5.7M-6.3M
 
 
 
 
 
Other Assets256.0K79.0K54.0K50.0K
 
 
 
 
 
Total Assets81.5M162.4M156.8M464.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.3M4.6M0.004.1M
 
 
 
 
Short Term Debt350.0K291.0K195.0K223.0K
 
 
 
 
 
Accrued Expenses4.0M4.0M5.6M6.0M
 
 
 
 
 
Other Current Liabilities4.0M4.0M12.0M6.0M
 
 
 
 
 
Other Liabilities9.1M9.4M13.1M14.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt347.0K56.0K279.0K231.0K
 
 
 
 
 
Total Liabilities9.5M9.5M13.3M14.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity72.0M153.0M143.5M449.6M
 
 
 
 
 
Total Shareholder Equity72.0M153.0M143.5M449.6M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding79.6M96.8M103.6M136.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.